Approval · Notice of Compliance 288 · 2004
CYTOSAR: Notice of Compliance 288
Issued March 23, 2004
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 288
- Date
- March 23, 2004
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Antileukemic Agent
Products in this notice
Medicinal ingredients
- CYTARABINE 100 MG per 5ML
- CYTARABINE 500 MG per 10ML
- CYTARABINE 1 G per VIAL
- CYTARABINE 2 G per VIAL